The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0745
Bid: 0.074
Ask: 0.075
Change: 0.0015 (2.05%)
Spread: 0.001 (1.351%)
Open: 0.073
High: 0.0745
Low: 0.073
Prev. Close: 0.073
IRON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Facilities Agreement

3 Feb 2020 07:00

RNS Number : 6568B
Ironveld PLC
03 February 2020
 

IRONVELD PLC

("Ironveld" or the "Company")

 

Loan Facilities Agreement

Ironveld is pleased to announce that the Company has entered into definitive agreements with a consortium of high net worth investors (the "Lenders") and existing shareholders to raise, in aggregate, approximately £260,000 through short term unsecured loan facilities ("Loan Facilities"). It is intended that the proceeds from the Loan Facilities will be used for working capital purposes while the Company continues to engage with potential funders for its high purity iron powder, vanadium and titanium project in South Africa.

Highlights:

·; Total sum available under the Loan Facilities is £260,000.

 

·; The Loan will be disbursed in tranches: £110,000 by 14 February 2020 and three further monthly tranches of £50,000 at the Company's election until the full £260,000 has been lent.

 

·; Each tranche of the loan will mature six months from the date of receipt of funds by Ironveld.

 

·; The Company has issued a total of 26,000,000 warrants to subscribe for ordinary shares in the Company at a subscription price of 1p per share to the Lenders, pro rata to the amount of each loan (the "Warrants"). The Warrants have a two year life and Lenders may use outstanding balances under the Loan Facilities to exercise Warrants.

 

·; The Lenders may elect to receive any interest payments due under the Loan Facilities in ordinary shares at a price of 1p each.

 

·; Participation of Ironveld's largest shareholder and Chairman in the Loan Facilities demonstrates support.

 

The Board believes that the draw down on the Loan Facilities will provide the Company with sufficient cash resources to enable it to operate until May 2020, by which time it hopes to have secured a transaction with a strategic financing partner.

Martin Eales, Chief Executive Officer, commented:

"I have been highly encouraged by the discussions we have had so far with parties potentially interested in participating in the financing for our project. Until we are in a position to conclude this financing, the Loan Facilities announced today are extremely helpful in ensuring that our modest short-term working capital requirements are met.

"Additionally, any issue of new shares via the Warrants or in interest payments will be at a substantial 60 per cent premium to the underlying share price, thereby minimising the potential dilution for shareholders."

Terms and Conditions of the Loan Facilities

The total sum available under the Loan Facilities is £260,000. The Loan Facilities have a six month term from draw down of funds, are unsecured and carry an interest rate of eight per cent per year. The Lenders, at their sole discretion, may elect to receive the due interest in shares of Borrower with a deemed price of 1p per share, such election to be made by Lenders at least 10 business days before the Repayment Date. The interest shall accrue daily and shall be payable on the Repayment Date.

The Loan will be disbursed in tranches: £110,000 by 14 February 2020 and three further monthly tranches of £50,000 at the Company's election on the 20th of each month thereafter until the full £260,000 has been lent.

If the Company fails to make any payment due on the due date for payment, interest on the unpaid amount shall accrue daily, from the date of non-payment to the date of actual payment (both before and after judgment), at an additional five per cent.

The Company has issued a total of 26,000,000 warrants to subscribe for ordinary shares in the Company at a subscription price of 1p per share to the Lenders, pro rata to the amount of each loan (the "Warrants"). The Warrants have a two year life and Lenders may use outstanding balances under the Loan Facilities to exercise Warrants.

Should the Company carry out a capital reorganisation, subdivision or consolidation during the warrant term, the Company will redenominate the warrant strike price to reflect the pre-reorganisation terms.

Related Party Transaction

Tracarta Limited and Giles Clarke have contributed £50,000 and £10,000 respectively to the Loan Facilities and been issued with 5,000,000 and 1,000,000 Warrants respectively. Tracarta Limited holds 12.27 per cent of the issued share capital in the Company, and Giles Clarke is the Company's Chairman. Therefore both are related parties for the purposes of the AIM Rules for Companies. Accordingly, the participation of the Related Parties in the Loan Facilities constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies.

The independent directors of Ironveld, being all those except Giles Clarke, having consulted with the Company's Nominated Adviser finnCap, consider that the terms of the Loan Facilities are fair and reasonable insofar as the Company's shareholders are concerned.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

For further information, please contact:

Ironveld plc

Giles Clarke, Chairman

Martin Eales, Chief Executive Officer

 

 

c/o Blytheweigh

+44 20 7138 3204

 

finnCap (Nomad and Broker)

Christopher Raggett / Hannah Boros

 

 

+44 20 7220 0500

Blytheweigh

Tim Blythe / Megan Ray

 

+44 20 7138 3204

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRUPUGGPUPUGUP
Date   Source Headline
3rd Feb 20207:00 amRNSLoan Facilities Agreement
10th Jan 202012:45 pmRNSGrant of Share Options
10th Jan 202010:20 amRNSResult of AGM
24th Dec 20197:00 amRNSPublication of Annual Report and Notice of AGM
6th Dec 20197:00 amRNSAppointment of Chief Executive Officer ("CEO")
5th Dec 20197:00 amRNSFinal results for the year ended 30 June 2019
22nd Oct 20197:00 amRNSBlocklisting Return
30th Sep 20197:00 amRNSUpdate on Strategic Review
24th Sep 20197:00 amRNSDirectorate Change
19th Sep 20197:00 amRNSDirectorate Change
12th Aug 20197:00 amRNSUpdate on Strategic Review
16th Jul 20198:00 amRNSPublication of Research
2nd Jul 20197:00 amRNSStrategic Review
5th Jun 20197:00 amRNSUpdate on off-take discussions
23rd Apr 20197:00 amRNSBlocklisting Return
28th Mar 20197:00 amRNSInterim results for the 6 months ended 31 Dec 2018
19th Feb 20197:00 amRNSPlacing to raise £1.1 million
14th Feb 20197:00 amRNSUpdate on bulk sampling programme
18th Jan 201911:30 amRNSResult of AGM
18th Jan 20197:00 amRNSCompany Update
21st Dec 201810:25 amRNSNotice of AGM
7th Dec 20187:00 amRNSFinal results for the year ended 30 June 2018
19th Nov 20187:00 amRNSPlacing to raise £400,000
7th Nov 20182:15 pmRNSNotification of major holdings
22nd Oct 20187:00 amRNSBlock listing Interim Review
26th Sep 20187:00 amRNSIronveld supplies potential off-take partner
12th Jul 20185:02 pmRNSHolding(s) in Company
9th Jul 20187:00 amRNSDirector/PDMR Shareholding
23rd Apr 20187:00 amRNSBlocklisting Return
28th Mar 20187:00 amRNSInterim results for the 6 months ended 31 Dec 2017
28th Feb 20187:00 amRNSCompany Update
31st Jan 20189:00 amRNSHolding(s) in Company
23rd Jan 20185:18 pmRNSResult of AGM
23rd Jan 20189:45 amRNSTR-1: Notification of major holdings
19th Dec 20177:00 amRNSAppointment of Non-Executive Director
7th Dec 20177:00 amRNSFinal results for the year ended 30 June 2017
27th Nov 20177:00 amRNSPlacing to raise £1.765 million
30th Oct 201712:10 pmRNSHolding(s) in Company
23rd Oct 20177:00 amRNSBlocklisting Return
12th Oct 20177:00 amRNSCompany Update
4th Oct 201710:45 amRNSHolding(s) in Company
25th Jul 20179:07 amRNSHolding(s) in Company
24th Jul 20177:00 amRNSCompany Update
10th Jul 20171:29 pmRNSResult of General Meeting
21st Jun 20175:30 pmRNSPlacing, Potential Acquisition and Notice of GM
28th Apr 20177:00 amRNSGranting of Licenses
25th Apr 20172:28 pmRNSBlocklisting Return
11th Apr 20177:00 amRNSPlanned acquisition of smelting business
29th Mar 20177:00 amRNSInterim results for six months ended 31 Dec 2016
2nd Feb 201711:02 amRNSConversion of consultants fees into equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.